Jen‐Shi Chen
About
Jen‐Shi Chen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health.
According to data from OpenAlex, Jen‐Shi Chen has authored 246 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Oncology, 81 papers in Pulmonary and Respiratory Medicine and 75 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jen‐Shi Chen's work include Palliative Care and End-of-Life Issues (69 papers), Gastric Cancer Management and Outcomes (50 papers) and Cancer survivorship and care (38 papers). Jen‐Shi Chen is often cited by papers focused on Palliative Care and End-of-Life Issues (69 papers), Gastric Cancer Management and Outcomes (50 papers) and Cancer survivorship and care (38 papers). Jen‐Shi Chen collaborates with scholars based in Taiwan, United States and South Korea. Jen‐Shi Chen's co-authors include Wen‐Chi Chou, Siew Tzuh Tang, Yung‐Jue Bang, Wen‐Cheng Chang, Dongrui R. Lu, Eric Van Cutsem, Juan W. Valle, Éric Raymond, Ivan Borbath and Richard C. Chao and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
In The Last Decade
Jen‐Shi Chen
242 papers receiving 6.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jen‐Shi Chen Taiwan | 32 | 3.6k | 1.9k | 1.8k | 1.4k | 1.2k | 246 | 6.6k | ||
| Lene Mellemkjær Denmark | 55 | 2.6k 0.7× | 1.5k 0.8× | 2.5k 1.4× | 1.9k 1.4× | 522 0.4× | 209 | 11.4k | ||
| Emanuela Scarpi Italy | 46 | 3.5k 1.0× | 1.8k 1.0× | 754 0.4× | 886 0.6× | 423 0.3× | 265 | 7.0k | ||
| Eleanor McFadden United States | 11 | 5.0k 1.4× | 3.2k 1.7× | 1.0k 0.6× | 2.1k 1.5× | 371 0.3× | 13 | 10.1k | ||
| Jordan M. Cloyd United States | 42 | 3.4k 1.0× | 1.8k 0.9× | 1.2k 0.7× | 2.9k 2.0× | 382 0.3× | 335 | 6.7k | ||
| Þorvarður R. Hálfdánarson United States | 35 | 4.3k 1.2× | 985 0.5× | 3.2k 1.8× | 1.1k 0.8× | 1.8k 1.5× | 267 | 6.4k | ||
| Paul F. Engstrom United States | 41 | 3.5k 1.0× | 1.4k 0.7× | 999 0.6× | 1.4k 1.0× | 350 0.3× | 126 | 7.1k | ||
| Melinda A. Maggard United States | 39 | 3.2k 0.9× | 1.4k 0.7× | 856 0.5× | 4.0k 2.8× | 332 0.3× | 82 | 8.0k | ||
| Olivier Mir France | 43 | 2.9k 0.8× | 2.8k 1.4× | 655 0.4× | 760 0.5× | 285 0.2× | 287 | 6.4k | ||
| Alexander S. Rosemurgy United States | 47 | 2.8k 0.8× | 1.9k 1.0× | 1.4k 0.8× | 5.0k 3.6× | 274 0.2× | 362 | 8.7k | ||
| Peter C. Huijgens Netherlands | 42 | 2.0k 0.6× | 729 0.4× | 418 0.2× | 462 0.3× | 390 0.3× | 182 | 6.8k |
Countries citing papers authored by Jen‐Shi Chen
Since
Specialization
Citations
This map shows the geographic impact of Jen‐Shi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jen‐Shi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jen‐Shi Chen more than expected).
Fields of papers citing papers by Jen‐Shi Chen
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jen‐Shi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jen‐Shi Chen. The network helps show where Jen‐Shi Chen may publish in the future.
Co-authorship network of co-authors of Jen‐Shi Chen
This figure shows the co-authorship network connecting the top 25 collaborators of Jen‐Shi Chen. A scholar is included among the top collaborators of Jen‐Shi Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jen‐Shi Chen. Jen‐Shi Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Shen, Lin, Kohei Shitara, Jen‐Shi Chen, et al.. (2024). GEMINI-Gastric: A phase 2 study of novel treatment combinations in patients with locally advanced unresectable or metastatic gastric cancers.. Journal of Clinical Oncology. 42(16_suppl). TPS4182–TPS4182.
2.
Su, Yung‐Yeh, Nai‐Jung Chiang, Yi‐Hsin Yang, et al.. (2023). Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer. Cancers. 15(4). 1008–1008.
3.
Wen, Fur‐Hsing, Chia‐Hsun Hsieh, Po‐Jung Su, et al.. (2023). Factors Associated With Family Surrogate Decisional-Regret Trajectories. Journal of Pain and Symptom Management. 67(3). 223–232.e2.
4.
Su, Yung‐Yeh, Nai‐Jung Chiang, Tai‐Jan Chiu, et al.. (2023). Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation. Biomedical Journal. 47(3). 100696–100696.
5.
Shen, Wen‐Chi, Ming‐Mo Hou, Tai‐Lin Huang, et al.. (2022). Transdermal buprenorphine improves overall quality of life and symptom severity in cancer patients with pain. Journal of Clinical Nursing. 32(3-4). 539–547.
6.
Le, Puo‐Hsien, Chia‐Jung Kuo, Tsung‐Hsing Chen, et al.. (2022). Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery Plus Palliative Chemotherapy or In-Front Surgery Alone. Journal of Personalized Medicine. 12(4). 555–555.
7.
Wu, Chiao‐En, Wen‐Kuan Huang, Wen‐Chi Chou, et al.. (2021). Establishment of a Pretreatment Nomogram to Predict the 6-Month Mortality Rate of Patients with Advanced Biliary Tract Cancers Undergoing Gemcitabine-Based Chemotherapy. Cancers. 13(13). 3139–3139.
8.
Huang, Wen‐Kuan, et al.. (2021). A Nomogram Predicting Progression Free Survival in Patients with Gastrointestinal Stromal Tumor Receiving Sunitinib: Incorporating Pre-Treatment and Post-Treatment Parameters. Cancers. 13(11). 2587–2587.
9.
Chen, Chen Hsiu, Fur‐Hsing Wen, Wen‐Chi Chou, et al.. (2021). Factors associated with distinct prognostic‐awareness‐transition patterns over cancer patients’ last 6 months of life. Cancer Medicine. 10(22). 8029–8039.
10.
Wu, Chiao‐En, Da‐Wei Yeh, Wen‐Kuan Huang, et al.. (2020). Chromosomal Instability May Not Be a Predictor for Immune Checkpoint Inhibitors from a Comprehensive Bioinformatics Analysis. Life. 10(11). 276–276.
11.
Chen, Chen Hsiu, Jen‐Shi Chen, Fur‐Hsing Wen, et al.. (2019). An Individualized, Interactive Intervention Promotes Terminally Ill Cancer Patients' Prognostic Awareness and Reduces Cardiopulmonary Resuscitation Received in the Last Month of Life: Secondary Analysis of a Randomized Clinical Trial. Journal of Pain and Symptom Management. 57(4). 705–714.e7.
12.
Hung, Yen‐Ni, Fur‐Hsing Wen, Tsang-Wu Liu, Jen‐Shi Chen, & Siew Tzuh Tang. (2018). Hospice Exposure Is Associated With Lower Health Care Expenditures in Taiwanese Cancer Decedents' Last Year of Life: A Population-Based Retrospective Cohort Study. Journal of Pain and Symptom Management. 55(3). 755–765.e5.
13.
Wen, Fur‐Hsing, Jen‐Shi Chen, Wen‐Chi Chou, et al.. (2018). Factors Predisposing Terminally Ill Cancer Patients' Preferences for Distinct Patterns/States of Life-Sustaining Treatments Over Their Last Six Months. Journal of Pain and Symptom Management. 57(2). 190–198.e2.
14.
Wen, Fur‐Hsing, Jen‐Shi Chen, Wen‐Chi Chou, et al.. (2018). Family Caregivers' Subjective Caregiving Burden, Quality of Life, and Depressive Symptoms Are Associated With Terminally Ill Cancer Patients' Distinct Patterns of Conjoint Symptom Distress and Functional Impairment in Their Last Six Months of Life. Journal of Pain and Symptom Management. 57(1). 64–72.
15.
Wen, Fur‐Hsing, Jen‐Shi Chen, Po‐Jung Su, et al.. (2018). Terminally Ill Cancer Patients' Concordance Between Preferred Life-Sustaining Treatment States in Their Last Six Months of Life and Received Life-Sustaining Treatment States in Their Last Month: An Observational Study. Journal of Pain and Symptom Management. 56(4). 509–518.e3.
16.
Tang, Siew Tzuh, Fur‐Hsing Wen, Wen‐Cheng Chang, et al.. (2017). Preferences for Life-Sustaining Treatments Examined by Hidden Markov Modeling Are Mostly Stable in Terminally Ill Cancer Patients' Last Six Months of Life. Journal of Pain and Symptom Management. 54(5). 628–636.e2.
17.
Tang, Siew Tzuh, Chen Hsiu Chen, Fur‐Hsing Wen, et al.. (2017). Accurate Prognostic Awareness Facilitates, Whereas Better Quality of Life and More Anxiety Symptoms Hinder End-of-Life Care Discussions: A Longitudinal Survey Study in Terminally Ill Cancer Patients' Last Six Months of Life. Journal of Pain and Symptom Management. 55(4). 1068–1076.
18.
Chen, Jen‐Shi, et al.. (2015). Cutaneous Adverse Events of Targeted Anticancer Therapy: A Review of Common Clinical Manifestations and Management. SHILAP Revista de lepidopterología.
19.
Tang, Siew Tzuh, Fur‐Hsing Wen, Chia‐Hsun Hsieh, et al.. (2015). Preferences for Life-Sustaining Treatments and Associations With Accurate Prognostic Awareness and Depressive Symptoms in Terminally Ill Cancer Patients' Last Year of Life. Journal of Pain and Symptom Management. 51(1). 41–51.e1.
20.
Wang, Hung‐Ming, Hsien‐Kun Chang, Chia‐Hsun Hsieh, et al.. (2013). Cisplatin, tegafur-uracil and leucovorin plus mitomycin C: an acceptably effective and toxic regimen for patients with recurrent or metastatic nasopharyngeal carcinoma. Biomedical Journal. 36(5). 229–229.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Lene Mellemkjær Breakdown of academic impact, for papers by Emanuela Scarpi Breakdown of academic impact, for papers by Eleanor McFadden Breakdown of academic impact, for papers by Jordan M. Cloyd Breakdown of academic impact, for papers by Þorvarður R. Hálfdánarson Breakdown of academic impact, for papers by Paul F. Engstrom Breakdown of academic impact, for papers by Melinda A. Maggard Breakdown of academic impact, for papers by Olivier Mir Breakdown of academic impact, for papers by Alexander S. Rosemurgy Breakdown of academic impact, for papers by Peter C. Huijgens